In diagnostic immunohistochemistry, breast cancer is characterized based on the expression of estrogen and progesterone hormone receptors (ER and PR, respectively) and the human epidermal growth factor receptor 2 (HER2) [6,9,20,21]. The gene discussed is ERBB2; the disease is breast carcinoma.